FDA Approved: TACROLIMUS — Supplemental Application (Sandoz Inc.)

View source ↗

Summary

FDA approved a supplemental application for tacrolimus submitted by Sandoz Inc. (ANDA065461), authorizing a tacrolimus product as part of the generic approval p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Transplant Rejection
• Kidney Transplant Rejection
• Liver Transplant Rejection

Drugs mentioned

• Tacrolimus (Tacrolimus)

Snippet

SUPPL AP for TACROLIMUS (TACROLIMUS)